These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 15776000)

  • 1. HIV/AIDS in 2004: the epidemiologist's point of view.
    Girardi E; Lauria FN; Ippolito G
    Cell Death Differ; 2005 Aug; 12 Suppl 1():837-44. PubMed ID: 15776000
    [No Abstract]   [Full Text] [Related]  

  • 2. Antiretroviral drug resistance surveillance among drug-naive HIV-1-infected individuals in Gauteng Province, South Africa in 2002 and 2004.
    Pillay V; Ledwaba J; Hunt G; Rakgotho M; Singh B; Makubalo L; Bennett DE; Puren A; Morris L
    Antivir Ther; 2008; 13 Suppl 2():101-7. PubMed ID: 18575198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance to antiretroviral drugs: a threat to the prevention and treatment of pediatric HIV infection.
    Krogstad PA
    J Infect Dis; 2007 May; 195(10):1393-5. PubMed ID: 17436216
    [No Abstract]   [Full Text] [Related]  

  • 4. HIV drug resistance transmission threshold survey in Bangkok, Thailand.
    Sirivichayakul S; Phanuphak P; Pankam T; O-Charoen R; Sutherland D; Ruxrungtham K
    Antivir Ther; 2008; 13 Suppl 2():109-13. PubMed ID: 18575199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiretroviral therapy improves cognitive impairment in HIV+ individuals in sub-Saharan Africa.
    Sacktor N; Nakasujja N; Skolasky R; Robertson K; Wong M; Musisi S; Ronald A; Katabira E
    Neurology; 2006 Jul; 67(2):311-4. PubMed ID: 16864825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [HIV-infection].
    Wasmuth JC; Rockstroh JK
    Dtsch Med Wochenschr; 2007 Mar; 132(13):673-83; quiz 685-6. PubMed ID: 17377882
    [No Abstract]   [Full Text] [Related]  

  • 7. [Severe opportunistic infections in HIV-positive adults in sub-Saharan Africa].
    Anglaret X
    Med Trop (Mars); 2006 Aug; 66(4):343-5. PubMed ID: 16999042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [To finish theoretically with AIDS].
    Nau JY
    Rev Med Suisse; 2008 Dec; 4(183):2705. PubMed ID: 19157288
    [No Abstract]   [Full Text] [Related]  

  • 9. Trends in the European HIV/AIDS epidemic: a perspective from Italy.
    Madeddu G; Rezza G; Mura MS
    Expert Rev Anti Infect Ther; 2009 Feb; 7(1):25-36. PubMed ID: 19622055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perspectives on the pediatric HIV/AIDS pandemic: catalyzing access of children to care and treatment.
    Kline MW
    Pediatrics; 2006 Apr; 117(4):1388-93. PubMed ID: 16585337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surveillance of transmitted HIV drug resistance in the Manzini-Mbabane corridor, Swaziland, in 2006.
    Maphalala G; Okello V; Mndzebele S; Gwebu P; Mulima N; Dlamini S; Nhlabatsi B; Ginindza T; Ghebrenegus Y; Ntilivamunda A; Mwanyumba F; Ledwaba J; Pillay V; Bennett DE
    Antivir Ther; 2008; 13 Suppl 2():95-100. PubMed ID: 18575197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV drug resistance threshold survey using specimens from voluntary counselling and testing sites in Hanoi, Vietnam.
    Nguyen HT; Duc NB; Shrivastava R; Tran TH; Nguyen TA; Thang PH; McNicholl JM; Leelawiwat W; Chonwattana W; Sidibe K; Fujita M; Luu CM; Kakkar R; Bennett DE; Kaplan J; Cosimi L; Wolfe MI
    Antivir Ther; 2008; 13 Suppl 2():115-21. PubMed ID: 18575200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of HIV drug resistance during antiretroviral treatment and clinical progression in a large European cohort study.
    Cozzi-Lepri A; Phillips AN; Clotet B; Mocroft A; Ruiz L; Kirk O; Lazzarin A; Wiercinska-Drapalo A; Karlsson A; Lundgren JD;
    AIDS; 2008 Oct; 22(16):2187-98. PubMed ID: 18832882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV/AIDS in the last 10 years.
    Osman AS
    East Mediterr Health J; 2008; 14 Suppl():S90-6. PubMed ID: 19205608
    [No Abstract]   [Full Text] [Related]  

  • 15. The status of HIV-1 resistance to antiretroviral drugs in sub-Saharan Africa.
    Hamers RL; Derdelinckx I; van Vugt M; Stevens W; Rinke de Wit TF; Schuurman R;
    Antivir Ther; 2008; 13(5):625-39. PubMed ID: 18771046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transmitted drug-resistant HIV-1 in primary HIV-1 infection; incidence, evolution and impact on response to antiretroviral therapy.
    Fox J; Dustan S; McClure M; Weber J; Fidler S
    HIV Med; 2006 Oct; 7(7):477-83. PubMed ID: 16925735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AIDS in the Third World: how to stop the HIV infection?
    De Clercq E
    Verh K Acad Geneeskd Belg; 2007; 69(2):65-80. PubMed ID: 17550059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continued correspondence 'Will ART rollout in Africa drive an epidemic of drug-resistant HIV?'.
    Hastings IM; Lalloo DG; Khoo SH
    AIDS; 2007 Jan; 21(2):258-9; author reply 259-60. PubMed ID: 17197825
    [No Abstract]   [Full Text] [Related]  

  • 19. Finding patients eligible for antiretroviral therapy using TB services as entry point for HIV treatment.
    Bwire R; Nagelkerke NJ; Borgdorff MW
    Trop Med Int Health; 2006 Oct; 11(10):1567-75. PubMed ID: 17002731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. World Health Organization surveys to monitor HIV drug resistance prevention and associated factors in sentinel antiretroviral treatment sites.
    Jordan MR; Bennett DE; Bertagnolio S; Gilks CF; Sutherland D
    Antivir Ther; 2008; 13 Suppl 2():15-23. PubMed ID: 18575188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.